Q3 2013 13F Holders as of 30 Sep 2013
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
254,691,824
-
Total 13F shares
-
5,938,217
-
Share change
-
+57,504
-
Total reported value
-
$450,245,264
-
Price per share
-
$75.82
-
Number of holders
-
17
-
Value change
-
+$4,359,847
-
Number of buys
-
5
-
Number of sells
-
7
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q3 2013
As of 30 Sep 2013,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,938,217 shares.
The largest 10 holders included
LAZARD ASSET MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, Retirement Systems of Alabama, Zurcher Kantonalbank (Zurich Cantonalbank), HARTFORD INVESTMENT MANAGEMENT CO, PDT Partners, LLC, State of Tennessee, Treasury Department, DIAM Co., Ltd., BANK OF MONTREAL /CAN/, and Advantus Capital Management Inc.
This page lists
17
institutional shareholders reporting positions in this security
for the Q3 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.